Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Endocrinology · Primary Aldosteronism

Primary Aldosteronism: Unilateral or Bilateral Disease?

At a Glance

The key difference is whether one or both adrenal glands overproduce aldosterone. One-gland disease may be treated by removing the affected gland, while two-gland disease is usually managed with long-term medication. Adrenal venous sampling can help determine whether surgery is appropriate.

When you are diagnosed with primary aldosteronism, one of the most critical steps is determining whether the excess aldosterone is coming from one adrenal gland (unilateral) or both (bilateral). This distinction, known as lateralization, strongly influences your treatment plan, though your final path will also depend on your overall health, kidney function, and personal preferences.

In short, unilateral primary aldosteronism is most commonly caused by a single benign tumor on one adrenal gland and can often be treated with surgery [1][2]. Bilateral primary aldosteronism means both adrenal glands are overactive; because removing both glands would severely compromise your body’s ability to produce essential hormones, this form is usually treated with long-term medication instead [2][3].

Quick Comparison

Feature Unilateral Disease Bilateral Disease
Most Common Cause Aldosterone-Producing Adenoma (APA) Bilateral Idiopathic Hyperaldosteronism (IHA)
What is Happening? One gland releases too much aldosterone. Both glands release too much aldosterone.
Usual Treatment Surgery (Adrenalectomy) or medication Long-term medication (MRAs)

Unilateral Primary Aldosteronism

Unilateral disease means only one of your two adrenal glands is overproducing aldosterone. This is most commonly caused by an Aldosterone-Producing Adenoma (APA), a small, non-cancerous (benign) tumor that forms on the gland [1]. Less commonly, it can be caused by unilateral hyperplasia (enlargement) of just one gland.

If you are a good candidate for surgery and prefer a surgical route, the standard treatment for unilateral disease is adrenalectomy—the surgical removal of the overactive gland [2][3]. Medical therapy is an alternative if surgery is not appropriate for you or if you decline it.

Once the abnormal gland is removed, the remaining healthy gland takes over normal hormone production. Surgery often cures the aldosterone excess and normalizes low potassium levels [4][5]. However, blood pressure improvement is not guaranteed; many patients still require some blood pressure medication after surgery [4][5]. After an adrenalectomy, your doctor will still need to monitor your blood pressure, potassium, and kidney function, as temporary potassium imbalances can sometimes occur post-surgery [6][7].

Bilateral Primary Aldosteronism

Bilateral disease means that both of your adrenal glands are overactive and producing too much aldosterone [1]. This is most often called Bilateral Idiopathic Hyperaldosteronism (IHA) or bilateral adrenal hyperplasia [1]. The tissue in both glands is hyperactive or enlarged rather than there being a single distinct tumor.

Because both glands are malfunctioning, surgery is rarely the standard treatment [3]. Instead, bilateral disease is managed with usually long-term, often lifelong, medication—specifically mineralocorticoid-receptor antagonists (MRAs) like spironolactone or eplerenone [3][8]. These drugs block the aldosterone hormone from damaging your body, helping to control your blood pressure and correct low potassium [9][10].

Medication Side Effects and Monitoring

While MRAs are highly effective, they do not remove the cause of the disease and they require careful monitoring. Because they help your body hold onto potassium, they can sometimes cause your potassium to become too high (hyperkalemia) or worsen kidney function [8][11].

Additionally, spironolactone can cause specific side effects, including breast tenderness, breast enlargement (gynecomastia), and menstrual or sexual side effects [8][12]. Eplerenone is an alternative that typically avoids these specific sexual side effects, though it can still affect potassium and kidney function [12]. Your doctor will routinely check your potassium, kidney function, and renin (a kidney hormone involved in blood pressure balance) to ensure you are on the right dose [8][3].

Why not just remove both adrenal glands?

Removing both adrenal glands creates a new, far more dangerous medical condition called adrenal insufficiency [13][14].

Your adrenal glands produce several essential hormones besides aldosterone, including cortisol, which helps you respond to stress and illness. If you remove both glands, your body can no longer produce these life-sustaining hormones [13]. You would be completely dependent on lifelong glucocorticoid and mineralocorticoid replacement [13][14]. In the event of severe physical stress (like an infection or surgery), you would require emergency stress-dosing of steroids or injectable hydrocortisone. Without this, you could experience an adrenal crisis, which is a life-threatening medical emergency [15]. Patients who must undergo bilateral adrenalectomy require intense education, emergency plans, and medical alert identification. For routine bilateral primary aldosteronism, medical management with MRAs is much safer [3][16].

How Doctors Tell the Difference

Standard imaging, like CT or MRI scans, cannot definitively tell your doctor whether your disease is unilateral or bilateral [17]. Small adenomas may not show up on a scan, and harmless, non-functioning nodules are very common, which can mislead doctors into thinking the disease is unilateral when it is actually bilateral [17][18].

To confirm whether one or both glands are overactive, specialists often recommend a specialized procedure called Adrenal Venous Sampling (AVS) [19]. During AVS, an expert compares the aldosterone and cortisol levels from the veins of each adrenal gland to see where the excess is coming from [19][4].

AVS is generally only recommended if you are considering surgery [4]. If you and your doctor have already decided that you will treat your condition with medication regardless of the cause, AVS may be unnecessary. Because AVS is a technically demanding procedure, it should be performed at an experienced medical center where the specific risks and limitations can be discussed.

Common questions in this guide

What is the difference between unilateral and bilateral primary aldosteronism?
Unilateral primary aldosteronism means one adrenal gland makes too much aldosterone, often because of a benign aldosterone-producing tumor. Bilateral disease means both glands are overactive and is often due to enlargement or overactivity of both glands. The distinction helps determine whether surgery or medication is more appropriate.
How do doctors determine whether primary aldosteronism affects one adrenal gland or both?
CT or MRI can show nodules but cannot reliably prove which gland is producing excess aldosterone. Adrenal venous sampling compares aldosterone and cortisol from the veins of both adrenal glands. It is generally considered when surgery is being considered.
Can surgery cure unilateral primary aldosteronism?
Removing the overactive adrenal gland may cure the aldosterone excess and often correct low potassium. Blood pressure does not always return to normal, so some people still need blood pressure medicine. Follow-up includes blood pressure, potassium, and kidney function checks.
Why is bilateral primary aldosteronism usually treated with medication?
Removing both adrenal glands would cause adrenal insufficiency because the body could no longer make essential hormones such as cortisol. Bilateral disease is therefore usually treated with long-term medicines such as spironolactone or eplerenone, which block aldosterone’s effects and help control blood pressure and potassium.
What side effects and tests should I expect with spironolactone or eplerenone?
These medicines can raise potassium and affect kidney function, so clinicians monitor potassium and kidney tests. Spironolactone may cause breast tenderness, breast enlargement, or menstrual and sexual side effects. Eplerenone usually causes fewer of these hormone-related effects but still requires monitoring.
Do I need adrenal venous sampling if I plan to take medication?
Adrenal venous sampling is mainly recommended when the result could determine whether you have surgery. If you and your doctor have already chosen medication regardless of whether one or both glands are involved, the procedure may not be necessary. Your specialist should weigh its potential benefits, risks, and technical limitations.

Get notified when new evidence is published on hyperaldosteronism.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Adrenal venous sampling interpretation and molecular imaging as localization tool in primary aldosteronism.

    Deniz S, Oettle M, Kroiss M, et al.

    Vitamins and hormones 2026; (130()):255-288 doi:10.1016/bs.vh.2025.11.002.

    PMID: 41638801
  2. 2

    Diagnosis and management of primary aldosteronism.

    Vilela LAP, Almeida MQ

    Archives of endocrinology and metabolism 2017; (61(3)):305-312 doi:10.1590/2359-3997000000274.

    PMID: 28699986
  3. 3

    Diagnosis and treatment of primary aldosteronism: practical clinical perspectives.

    Young WF

    Journal of internal medicine 2019; (285(2)):126-148 doi:10.1111/joim.12831.

    PMID: 30255616
  4. 4

    10 good reasons why adrenal vein sampling is the preferred method for referring primary aldosteronism patients for adrenalectomy.

    Rossi GP, Mulatero P, Satoh F

    Journal of hypertension 2019; (37(3)):603-611 doi:10.1097/HJH.0000000000001939.

    PMID: 30431526
  5. 5

    From bench to bedside: primary aldosteronism revisited.

    Wei J, Williams TA

    Endocrine connections 2026; (15(9)) doi:10.1530/EC-26-0524.

    PMID: 42644335
  6. 6

    Insufficiency of the zona glomerulosa of the adrenal cortex and progressive kidney insufficiency following unilateral adrenalectomy - case report and discussion.

    Kanarek-Kucner J, Stefański A, Barraclough R, et al.

    Blood pressure 2018; (27(5)):304-312 doi:10.1080/08037051.2018.1470460.

    PMID: 29742971
  7. 7

    Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma.

    Park KS, Kim JH, Ku EJ, et al.

    European journal of endocrinology 2015; (172(6)):725-31 doi:10.1530/EJE-15-0074.

    PMID: 25766046
  8. 8

    Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline.

    Adler GK, Stowasser M, Correa RR, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(9)):2453-2495 doi:10.1210/clinem/dgaf284.

    PMID: 40658480
  9. 9

    Treatment of Primary Aldosteronism.

    Parisien-La Salle S, Hundemer GL, Nehs MA, et al.

    Hypertension (Dallas, Tex. : 1979) 2026; (83(5)):e26238 doi:10.1161/HYPERTENSIONAHA.126.26238.

    PMID: 41808633
  10. 10

    Aldosterone-mineralocorticoid receptor interactions: new insights and therapeutic perspectives in primary aldosteronism.

    Yoshida Y, Shibata H

    Hypertension research : official journal of the Japanese Society of Hypertension 2026; (49(4)):1336-1342 doi:10.1038/s41440-026-02561-4.

    PMID: 41629686
  11. 11

    Outcomes of drug-based and surgical treatments for primary aldosteronism.

    Steichen O, Lorthioir A, Zinzindohoue F, et al.

    Advances in chronic kidney disease 2015; (22(3)):196-203.

    PMID: 25908468
  12. 12

    Pharmacological treatment of aldosterone excess.

    Deinum J, Riksen NP, Lenders JW

    Pharmacology & therapeutics 2015; (154()):120-33.

    PMID: 26213109
  13. 13

    Unilateral Adrenalectomy as a First-Line Treatment of Cushing's Syndrome in Patients With Primary Bilateral Macronodular Adrenal Hyperplasia.

    Debillon E, Velayoudom-Cephise FL, Salenave S, et al.

    The Journal of clinical endocrinology and metabolism 2015; (100(12)):4417-24 doi:10.1210/jc.2015-2662.

    PMID: 26451908
  14. 14

    PRKAR1A-negative familial Cushing's syndrome: two case reports.

    Lim LL, Kitan N, Paramasivam SS, et al.

    Journal of medical case reports 2015; (9()):277 doi:10.1186/s13256-015-0757-7.

    PMID: 26619967
  15. 15

    Effect of surgical versus conservative management on cardiovascular outcomes in patients with bilateral adrenal tumours and cortisol excess: an international, retrospective cohort study.

    Nowak E, Viëtor CL, Feelders RA, et al.

    The lancet. Diabetes & endocrinology 2026; (14(3)):202-215 doi:10.1016/S2213-8587(25)00302-X.

    PMID: 41579871
  16. 16

    Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.

    Naruse M, Katabami T, Shibata H, et al.

    Endocrine journal 2022; (69(4)):327-359 doi:10.1507/endocrj.EJ21-0508.

    PMID: 35418526
  17. 17

    Adrenal venous sampling for primary aldosteronism: laboratory medicine best practice.

    Kline G, Holmes DT

    Journal of clinical pathology 2017; (70(11)):911-916 doi:10.1136/jclinpath-2017-204423.

    PMID: 28893861
  18. 18

    Adrenal Venous Sampling in Young Patients with Primary Aldosteronism. Extravagance or Irreplaceable?

    Gkaniatsa E, Sakinis A, Palmér M, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(5)):e2087-e2095 doi:10.1210/clinem/dgab047.

    PMID: 33507307
  19. 19

    Efficient screening of patients with aldosterone-producing adenoma using the ACTH stimulation test.

    Kita T, Furukoji E, Sakae T, Kitamura K

    Hypertension research : official journal of the Japanese Society of Hypertension 2019; (42(6)):801-806 doi:10.1038/s41440-018-0191-5.

    PMID: 30622316

This page explains unilateral and bilateral primary aldosteronism for informational purposes only and does not constitute medical advice. Your endocrinologist and surgeon can interpret your results and recommend the safest option for you.